Rezolute, Inc. (RZLT)
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
$278.61M
Mr. Nevan Charles Elam J.D.
42.00
Redwood City, CA
May 13, 2013
-4.41
$-1.14
3.08
20.18
0.00%
-0.79
-0.00
0.35
0.00
19.60
-41.89%
-38.54%
Similar stocks (4)
Larimar Therapeutics, Inc.
LRMR
Eledon Pharmaceuticals, Inc.
ELDN
Reneo Pharmaceuticals, Inc.
RPHM
Clene Inc.
CLNN
ETF Exposure (14)
iShares Micro-Cap ETF
IWC
0.04039%
Dimensional U.S. Targeted Value ETF
DFAT
4.6086999999999994e-4%
Dimensional U.S. Small Cap ETF
DFAS
2.8112e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.8201e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (4)
Larimar Therapeutics, Inc.
LRMR
Eledon Pharmaceuticals, Inc.
ELDN
Reneo Pharmaceuticals, Inc.
RPHM
Clene Inc.
CLNN
ETF Exposure (14)
iShares Micro-Cap ETF
IWC
0.04039%
Dimensional U.S. Targeted Value ETF
DFAT
4.6086999999999994e-4%
Dimensional U.S. Small Cap ETF
DFAS
2.8112e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.8201e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%